Ads
related to: t cells- What Is CTCL?
CTCL Is A Rare From Of Cancer &
Has Several Subtypes. Learn More.
- Patient FAQs
Get Answers To Your Questions
About A MF & SS Treatment.
- Treatment Benefits
See The Patient Response Data &
Efficacy Of A MF & SS Treatment.
- Treatment Resources
Watch Helpful Videos Or Access
Patient Resources To Learn More.
- Patient Support Program
Get Ongoing & Personalized Support
Throughout Your Treatment Journey.
- What Is SS?
The Less Common CTCL Subtype That
Can Have Different Symptoms.
- What Is CTCL?
Search results
Study finds promising biomarker for cellular rejection after organ transplant
Medical Xpress· 12 hours agoACR occurs when a patient's immune cells, known as T cells, begin attacking the transplanted organ....
US FDA mandates label updates on CAR-T cancer therapies
WSAU Wausau· 2 hours ago(Reuters) - The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T...
A one-shot vaccine for COVID, flu and future viruses? Researchers say it's coming
Salon via Yahoo News· 16 hours agoA health worker injects a man with a shot of the Inavac vaccine for Covid-19 at the Jakarta...
Study Uncovers Potential Immunotherapy Approach for Rare Eye Cancer
Technology Networks· 1 day agoNew research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant...
T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations,...
Morningstar· 7 days agoSØBORG, Denmark, April 12, 2024 (GLOBE NEWSWIRE) -- Cbio A/S – Pioneering Next-Gen T-Cell Therapies for Solid Tumors, Unveils 2023 Financial Results and ...
Checkpoint Inhibitors: A New Hope for Cancer Treatment
Forbes· 2 days agoThis article is part of an ongoing series on checkpoint inhibitors, a novel cancer immunotherapy....
New Vaccine Could Protect Against Any Strain of a Virus With One Shot
Futurism via Yahoo News· 12 hours agoScientists seem to be close to creating a so-called "universal vaccine" that can protect against any...
Nanovials method for immune cell screening uncovers receptors that target prostate cancer
Phys.org· 3 days agoThe research is published in the journal Proceedings of the National Academy of Sciences. The...
Medigene to Present at Upcoming Scientific Conferences
Morningstar· 2 days agoMedigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell
Adaptimmune (ADAP) Down on End of Collaboration With Roche
Zacks· 4 days agoShares of ADAP were down 10% on the news. Both companies collaborated in 2021 to develop and commercialize allogeneic cell therapies to treat multiple oncology indications. The collaboration ...
